---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-008461"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2025-01-17T23:59:59+00:00"
generated_at: "2026-05-27T23:21:53.717961+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology adopts 2025 Inducement Plan, reserves 1.5M shares for new-hire equity awards

## Summary
- Board approved Inducement Plan on Jan 16, 2025; effective immediately.
- 1,500,000 shares of common stock reserved for issuance under the plan.
- Awards are limited to new employees as a material inducement to join the company, per Nasdaq Listing Rule 5635(c)(4).
- Plan terms are substantially similar to ALX's existing 2020 Equity Incentive Plan.
- No shareholder approval was required for adoption.

## SEC filing metadata
- accession: 0001193125-25-008461
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2025-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/0001193125-25-008461-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312525008461/d909443d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-008461
- JSON: https://secwatch.observer/filing/0001193125-25-008461.json
- Plain text: https://secwatch.observer/filing/0001193125-25-008461.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.